Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | STK17B | O94768 | 1/20 | 0.39 |
| ▸ | DUSP1 | P28562 | 1/20 | 0.38 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94584 | 1.00 | CYP1A2 (0.47) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL14080306 | 0.90 | MAPT (0.38) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL7839741 | 0.78 | MEN1 (0.38) | CYP1A2MAPTLMNASMN1; SMN2NPSR1 | |
| SCHEMBL1824532 | 0.77 | TDP1 (0.42) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL13299668 | 0.76 | NPC1 (0.50) | CYP1A2MAPTSMN1; SMN2HPGDF3 | |
| SCHEMBL22667801 | 0.74 | — | — | |
| SCHEMBL7839790 | 0.73 | ALDH1A1 (0.45) | CYP1A2MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL7848396 | 0.69 | MAPT (0.45) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL7848283 | 0.69 | MAPT (0.45) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL9585267 | 0.68 | CYP1A2 (0.52) | CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171537-A1 | TOPICAL VITAMIN C COMPOSITION | Topix Pharmaceuticals, Inc. (US) | 2023-05-03 | — | — | EP | disclosed |
| WO-2022010683-A1 | TOPICAL VITAMIN C COMPOSITION | TOPIX PHARMACEUTICALS, INC. (US) | 2022-01-13 | — | — | WO | disclosed |
| US-20080019929-A1 | Micro-Particulate Organic Uv Absorber Composition | CIBA SPECIALTY CHEMICALS CORP. | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080019929-A1 | Micro-Particulate Organic Uv Absorber Composition | PCNA, FASN, CCNO | CYP1A2 316/4885MAPT 439/4885CYP2D6 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.